Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes

Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes

Abstract Aims/Introduction We investigated the difference in efficacy and safety between discontinuation and maintaining of sulfonylurea when adding a sodium–glucose cotransporter 2 inhibitor. Materials and Methods In the present multicenter, prospective observational study, 200 patients with type 2...

Full description

Bibliographic Details
Main Authors: Kiyohiko Takahashi, Kyu Yong Cho, Akinobu Nakamura, Aika Miya, Arina Miyoshi, Chiho Yamamoto, Hiroshi Nomoto, Hirokatsu Niwa, Kiyohito Takahashi, Naoki Manda, Yoshio Kurihara, Shin Aoki, Yoichi M Ito, Tatsuya Atsumi, Hideaki Miyoshi
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:Journal of Diabetes Investigation
Subjects:
Glycated hemoglobin
Sodium–glucose cotransporter 2 inhibitor
Sulfonylurea
Online Access:https://doi.org/10.1111/jdi.12913

Internet

https://doi.org/10.1111/jdi.12913

Similar Items